Jain, Tania
Sauter, Craig S.
Shah, Gunjan L. http://orcid.org/0000-0002-9977-0456
Maloy, Molly A.
Chan, Jason
Scordo, Michael
Avecilla, Scott T.
Batlevi, Yakup
Dahi, Parastoo B. http://orcid.org/0000-0002-0794-3226
Batlevi, Connie W.
Lia Palomba, M.
Giralt, Sergio A.
Perales, Miguel-Angel
Article History
Received: 23 February 2019
Revised: 9 April 2019
Accepted: 11 April 2019
First Online: 21 May 2019
Compliance with ethical standards
:
: CS—Consultant on advisory boards for: Juno Therapeutics, Sanofi-Genzyme, Spectrum Pharmaceuticals, Novartis, Precision Biosciences, Kite, a Gilead Company and GSK. Research funds for investigator-initiated trials from: Juno Therapeutics and Sanofi-Genzyme. GS—Research funding from Janssen and Amgen. MS—Consultancy: Angiocrine Bioscience, Inc., McKinsey & Company. Scott Avecilla—Honoraria for presenting a project in partnership with Abbott Laboratories. CB—Research funding from Epizyme, Novartis, Janssen, BMS, Miragen, Mediimmune; Consultancy from Defined Health, GLG, Guidepoint Global; Honoraria from Dava Oncology. MLP—Advisory Board for Celgene, Consultant for Merck and Pharmacyclics. SG—Advisory Board for Amgen, Actinuum, Celgene, Johnson & Johnson, Jazz pharmaceutical, Takeda, Novartis, Kite, Spectrum Pharma; Research funding from Amgen, Actinuum, Celgene, Johnson & Johnson, Miltenyi, Takeda, Miguel-Angel Perales - Honoraria from Abbvie, Bellicum, Bristol-Myers Squibb, Incyte, Merck, Novartis, Nektar Therapeutics, and Takeda. He serves on DSMBs for Servier and Medigene, and the scientific advisory boards of MolMed and NexImmune. Research support for clinical trials from Incyte, Kite (Gilead) and Miltenyi Biotec.